Findings are based on a study of 88 men and 78 women with ANCA-associated vasculitis with glomerulonephritis and severe kidney disease at diagnosis.

Patients with vs without ANCA-associated vasculitis are significantly more likely to die after kidney transplantation and to experience postoperative infection. Patients with ANCA-associated ...

Standard treatment of ANCA-associated vasculitis generally consists of a remission induction regimen that includes the use of cyclophosphamide and high-dose glucocorticoids, followed by a ...

6 In patients with ANCA-associated vasculits ... Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo? Trends Immunol.

This study by the French Vasculitis Study Group 1 is not the first setback for methotrexate in the treatment of ANCA-associated vasculitis. A randomized, controlled trial of induction therapy in ...

Patients with GPA were two to three times as likely to experience disease relapse if they scored high on a patient-reported ...

The formation of neutrophil extracellular traps (NETs) is a common feature in the renal glomeruli of patients with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. The use of a DNA repair ...

Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 ...

Looking forward, we'll continue to leverage our expertise in nephrology and inflammation to bring TAVNEOS to even more ...

Amgen AMGN reported first-quarter 2024 adjusted earnings of $3.96 per share, which beat the Zacks Consensus Estimate of $3.76. Earnings declined 1% year over year due to higher operating costs and ...

Chronicity on kidney biopsy, not sex, predicts the risk of progression to ESKD at 12 months after diagnosis of AAV in patients with severe kidney disease. Progression to kidney failure at 12 ...